Nasdaq
$32.77▼ 0.06%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $300.3MShares out 9.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
29- 10.16Pre-market26.10.16 22:24425Other#●●●#●●●
Sanara MedTech Inc.
Sanara MedTech and MiMedx Group have received a 'Second Request' for additional information and documentary materials from the Federal Trade Commission (FTC) regarding their proposed merger. This request extends the waiting period under the HSR Act, and the completion of the merger remains subject to the expiration or termination of this waiting period.…more
$32.77-0.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16Pre-market26.10.16 22:208-KKey event
Sanara MedTech Inc.
Sanara MedTech and MiMedx Group received a 'Second Request' for additional information and documentary materials from the FTC on October 15, 2026, regarding their pending merger. This request extends the waiting period under the HSR Act, and the completion of the merger remains subject to the expiration or termination of this period and other closing conditions.…more
$32.77-0.06%vs prev closeView filingShare - 10.16Pre-market26.10.16 22:11425Other
Sanara MedTech Inc.
MiMedx and Sanara MedTech have received a 'Second Request' for additional information and documentary materials from the Federal Trade Commission (FTC) regarding their proposed merger. This action extends the waiting period under the HSR Act, and the completion of the merger remains subject to the expiration of this period and the satisfaction of other closing conditions.…more
$32.77-0.06%vs prev closeView filingShare
28 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.11After-hours26.08.12 05:10Bullish#●●●#●●●
사나라 메드테크, 2분기 매출 9% 성장 및 MIMEDX 인수 합의
사나라 메드테크는 2분기 매출이 전년 동기 대비 9% 증가한 2,810만 달러를 기록하며 견조한 성장세를 보였습니다. 회사는 최근 MIMEDX에 인수되는 계약을 체결했으며, 이를 통해 수술용 재생 의학 시장에서의 입지를 강화할 예정입니다.…more
$32.77-0.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUS